MT Kelleni - Expert Review of Anti-infective Therapy, 2022 - Taylor & Francis
Introduction Mediators of immunity and inflammation are playing a crucial role in COVID-19 pathogenesis and complications as demonstrated by several genetic and clinical studies …
Q He, TN Mok, TH Sin, J Yin, S Li, Y Yin… - JMIR Public Health …, 2023 - publichealth.jmir.org
Background: Gout is a common and debilitating condition that is associated with significant morbidity and mortality. Despite advances in medical treatment, the global burden of gout …
JV Pergolizzi, P Magnusson, JA LeQuang… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Opioid analgesia for acute painful conditions has come under increasing scrutiny with the public health crisis of opioid overdose, leading clinicians to seek nonopioid …
JPP Lorenzo, MHMZ Sollano, EO Salido… - … journal of rheumatic …, 2022 - Wiley Online Library
Background Gout is the most prevalent inflammatory arthritis in the Asia‐Pacific region and worldwide. This clinical practice guideline (CPG) aims to provide recommendations based …
Pragmatic randomised clinical trials aim to directly inform clinical or health policy decision making. Here, we systematically review methods and design of pragmatic trials of pain …
SF Keller, BF Mandell - Medical Clinics, 2021 - medical.theclinics.com
With a prevalence of 3.9% among all adults, and 9.7% in those older than 80, gout is the most common inflammatory arthritis. 1 An analysis of National Health and Nutrition …
E Karatza, G Ismailos, V Karalis - Xenobiotica, 2021 - Taylor & Francis
Colchicine is widely investigated for cardioprotection of COVID-19 patients since it can prevent the phenomenon of 'cytokine storm'and may reduce the complications arising from …
R Murdoch, MJ Barry, HK Choi, D Hernandez… - RMD open, 2021 - rmdopen.bmj.com
Objective To develop a Gout, Hyperuricaemia and Crystal-Associated Disease Network (G- CAN) common language definition of gout, with the goal of increasing public understanding …